Merz Therapeutics’ Activities at ISPRM 2026 Highlight the Importance of Patient-Centric Management in Upper and Lower Limb Spasticity: From Goal Setting to Optimal Dosing for Better Patient Outcomes

Contributed by: Business Wire

Logo

Tags

Biotechnology

Health

Science

Pharmaceutical

Research

ISPRM 2026

More Like This

Merz Therapeutics Submits Application to the European Medicines Agency for New Indication of XEOMIN® in Pediatric Spasticity

Merz Therapeutics to Present Broad Range of Clinical, Real-World and Mechanistic Data at TOXINS 2026

Merz Therapeutics Hosts Over 300 International Healthcare Professionals at its First Global “Merz Expert Connect Summit 2023”

Merz Aesthetics Presents New Data in the Field of Regenerative Aesthetics at the 2024 IMCAS World Congress

IMCAS 2024: Galderma to Present Latest Updates From Its Unparalleled Aesthetics Portfolio Reinforcing Its Leadership Position

Merz Aesthetics Sponsors Symposium Highlighting Market Trends With a Portfolio Approach at the 2025 Aesthetic and Anti-aging Medicine World Congress (AMWC)

AMWC 2025: Galderma Pushes the Innovation Frontier With Updates From Its Unparalleled Portfolio Designed to Meet the Needs of the Aesthetic Community

Merz Aesthetics Sponsors Symposium on Global Beauty Landscape and Presents New Insights Around Regenerative Aesthetics at the 2024 Aesthetic and Anti-Aging Medicine World Congress (AMWC)